We found that the ADC measured by DW‐MRI in the MARCH1 siRNA‐treated tumours was significantly higher than that in the negative siRNA‐treated tumours (P < 0.01; Figure 7B), with no significant difference between the control PBS‐treated and negative siRNA‐treated tumours. Here, MARCHF1 is linked to neoplasm.